Medicalsystem Biotechnology Co., Ltd (SHE:300439)

Market Cap	3.90B +0.7%
Revenue (ttm)	1.47B -19.2%
Net Income	94.17M -62.5%
EPS	0.24 -62.6%
Shares Out	384.32M
PE Ratio	41.52
Forward PE	n/a
Dividend	0.13 (1.34%)
Ex-Dividend Date	Jun 23, 2025

Volume	3,288,586
Average Volume	6,413,912
Open	10.28
Previous Close	10.15
Day's Range	10.11 - 10.28
52-Week Range	9.40 - 12.67
Beta	0.21
RSI	46.56
Earnings Date	Apr 29, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2003
• Employees: 2,104
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300439

Financial Performance

In 2024, SHE:300439's revenue was 1.74 billion, a decrease of -7.61% compared to the previous year's 1.89 billion. Earnings were 258.00 million, an increase of 0.56%.